Association of fish consumption and omega 3 supplementation with quality of life, disability and disease activity in an international cohort of people with multiple sclerosis

References

• Hansen T, Skytthe A, Stenager E, Concordance for multiple sclerosis in Danish twins: an update of a nationwide study. Mult Scler 2005;11(5):504–10. PubMed PMID: 16193885.
   PubMedGoogle Scholar
• Sawcer S, Hellenthal G, Pirinen M, Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011;476(7359):214–9. Epub 2011 August 13. doi: nature10251 [pii] 10.1038 /nature10251. PubMed PMID: 21833088; PubMed Central PMCID: PMC3182531.
   PubMed Web of Science ®Google Scholar
• Hadgkiss EJ, Jelinek GA, Weiland TJ, Health-related quality of life outcomes at 1 and 5 years after a residential retreat promoting lifestyle modification for people with multiple sclerosis. Neurol Sci 2012. Epub 2012 March 1. doi: 10.1007 /s10072-012-0982-4. PubMed PMID: 22367222.
   PubMedGoogle Scholar
• Li MP-M, Jelinek GA, Weiland TJ, Effect of a residential retreat promoting lifestyle modifications on health-related quality of life in people with multiple sclerosis. Qual Prim Care 2010;18(6):379–89. PubMed PMID: MEDLINE:21294980.
   PubMedGoogle Scholar
• van der Mei IA, Simpson S, Jr., Stankovich J, Taylor BV. Individual and joint action of environmental factors and risk of MS. Neurol Clin 2011;29(2):233–55. Epub 2011 March 29. doi: S0733-8619(10)00160-X [pii] 10.1016/j.ncl.2010.12.007. PubMed PMID: 21439439.
   PubMed Web of Science ®Google Scholar
• Jelinek GA, Hassed CS. Managing multiple sclerosis in primary care: are we forgetting something? Qual Prim Care 2009;17(1):55–61. PubMed PMID: MEDLINE:19281675.
   PubMedGoogle Scholar
• Erasmus U. Fats that heal, fats that kill: the complete guide to fats, oils, cholesterol and human health. 3rd ed. Summertown, TN: Alive Books; 2010.
   Google Scholar
• Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 2002;21(6):495–505. Epub 2002 December 14. PubMed PMID: 12480795.
   PubMed Web of Science ®Google Scholar
• Hadgkiss EJ, Jelinek GA, Weiland TJ, Methodology of an international study of people with multiple sclerosis recruited through web 2.0 platforms: demographics, lifestyle and disease characteristics. Neurol Res Int 2013; Article ID 580596, 12 pages. Available from: http://dx.doi.org/10.1155/2013/580596, Accessed 3 May 2013.
   PubMedGoogle Scholar
• Solari A, Filippini G, Mendozzi L, Validation of Italian multiple sclerosis quality of life 54 questionnaire. J Neurol Neurosurg Psychiatry 1999;67(2):158–62. PubMed PMID: 10406981; PubMed Central PMCID: PMCSource: NLM. PMC1736469.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Ogata K, Katagishi M, Validation of the Japanese-translated version Multiple Sclerosis Quality of Life-54 instrument. Rinsho Shinkeigaku - Clin Neurol 2004;44(7):417–21. PubMed PMID: 15384701.
   PubMedGoogle Scholar
• Acquadro C, Lafortune L, Mear I. Quality of life in multiple sclerosis: translation in French Canadian of the MSQoL-54. Health Qual Life Outcomes 2003;1:70. PubMed PMID: 14636427; PubMed Central PMCID: PMCSource: NLM. PMC317365.
   PubMedGoogle Scholar
• Hohol MJ, Orav EJ, Weiner HL. Disease steps in multiple sclerosis: a simple approach to evaluate disease progression. Neurology 1995;45(2):251–5. Epub 1995 February 1. PubMed PMID: 7854521.
   PubMed Web of Science ®Google Scholar
• Hohol MJ, Orav EJ, Weiner HL. Disease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression. Mult Scler 1999;5(5): 349.
   PubMed Web of Science ®Google Scholar
• Marrie RA, Cutter G, Tyry T, Changes in the ascertainment of multiple sclerosis. Neurology 2005;65(7):1066–70. PubMed PMID: 16217060.
   PubMed Web of Science ®Google Scholar
• Marrie RA, Cutter G, Tyry T, Does multiple sclerosis-associated disability differ between races? Neurology 2006;66(8):1235–40. PubMed PMID: 16636241.
   PubMed Web of Science ®Google Scholar
• Hadjimichael O, Vollmer T, Oleen-Burkey M, North American Research Committee on Multiple Sclerosis. Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey. Health Qual Life Outcomes 2008;6:100. PubMed PMID: 19014588; PubMed Central PMCID: PMCSource: NLM. PMC2596785.
   PubMedGoogle Scholar
• McKellar S, Horsley P, Chambers R, Development of the diet habits questionnaire for use in cardiac rehabilitation. Australian J Prim Health 2008;14(3):43–7.
   Google Scholar
• Swank RL. Multiple sclerosis: a correlation of its incidence with dietary fat. Am J Med Sci 1950;220:421–30.
   PubMed Web of Science ®Google Scholar
• Esparza ML, Sasaki S, Kesteloot H. Nutrition, latitude, and multiple sclerosis mortality: an ecologic study. Am J Epidemiol 1995;142(7):733–7. PubMed PMID: 7572944.
   PubMedGoogle Scholar
• Knox EG. Foods and diseases. Br J Prev Soc Med 1977;31(2):71–80. PubMed PMID: 884399.
   PubMedGoogle Scholar
• Das UN. Is there a role for saturated and long-chain fatty acids in multiple sclerosis? Nutrition 2003;19(2):163–6. PubMed PMID: 12591552.
   PubMedGoogle Scholar
• Zhang W, Li P, Hu X, Omega-3 polyunsaturated fatty acids in the brain: metabolism and neuroprotection. Front Biosci 2011;16:2653–70. Epub 2011 May 31. doi: 3878 [pii]. PubMed PMID: 21622201.
   Web of Science ®Google Scholar
• Gallai V, Sarchielli P, Trequattrini A, Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids. J Neuroimmunol 1995;56:143–53.
   PubMed Web of Science ®Google Scholar
• D'Hooghe MB, Haentjens P, Nagels G, De Keyser J. Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis. Eur J Neurol 2012;19(4):616–24. Epub 2011 November 29. doi: 10.1111 /j.1468–1331.2011.03596.x. PubMed PMID: 22117611.
   PubMedGoogle Scholar
• Swank RL, Dugan BB. Effect of low saturated fat diet in early and late cases of multiple sclerosis. Lancet 1990;336(8706):37–9. PubMed PMID: 0001973220.
   PubMed Web of Science ®Google Scholar
• Dworkin RH, Bates D, Millar JH, Paty DW. Linoleic acid and multiple sclerosis: a reanalysis of three double-blind trials. Neurology 1984;34(11):1441–5. PubMed PMID: 6387534.
   PubMedGoogle Scholar
• Bates D, Cartlidge NE, French JM, A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis. J Neurol Neurosurg Psychiatry 1989;52(1):18–22. PubMed PMID: 2540285.
   PubMed Web of Science ®Google Scholar
• Torkildsen O, Wergeland S, Bakke S, Omega-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial. Arch Neurol 2012;69(8):1044–51. Epub 2012 April 18. doi: archneurol.2012.283 [pii] 10.1001 /archneurol.2012.283. PubMed PMID: 22507886.
   PubMed Web of Science ®Google Scholar
• Corthals AP. Multiple sclerosis is not a disease of the immune system. Q Rev Biol. 2011;86(4):287–321. Epub 2012 March 6. PubMed PMID: 22384749.
   PubMedGoogle Scholar
• Hon GM, Hassan MS, van Rensburg SJ, Red blood cell membrane fluidity in the etiology of multiple sclerosis. J Membr Biol. 2009;232(1–3):25–34. Epub 2009 November 17. doi: 10.1007 /s00232-009-9213-1. PubMed PMID: 19915887.
   PubMedGoogle Scholar
• Holman RT, Johnson SB, Kokmen E. Deficiencies of polyunsaturated fatty acids and replacement by nonessential fatty acids in plasma lipids in multiple sclerosis. Proc Natl Acad Sci U S A 1989;86:4720–24.
   PubMed Web of Science ®Google Scholar
• Shinto L, Marracci G, Baldauf-Wagner S, Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis. Prostaglandins Leukot Essent Fatty Acids 2009;80(2–3):131–6. Epub 2009 January 28. doi: S0952-3278(08)00189-0 [pii] 10.1016 /j.plefa.2008.12.001. PubMed PMID: 19171471; PubMed Central PMCID: PMC2692605.
   PubMed Web of Science ®Google Scholar
• Marrie RA, Cutter G, Tyry T, Validation of the NARCOMS registry: diagnosis. Mult Scler 2007;13(6):770–5. Epub 2007 May 26. doi: 1352458506075031 [pii] 10.1177 /1352458506075031. PubMed PMID: 17525097.
   PubMedGoogle Scholar
• Jelinek G. Overcoming multiple sclerosis: an evidence-based guide to recovery Sydney, New South Wales: Allen and Unwin; 2010.
   Google Scholar